Technical Analysis for SBBP - Strongbridge Biopharma plc

Grade Last Price % Change Price Change
grade F 1.57 -4.85% -0.08
SBBP closed down 4.85 percent on Wednesday, November 13, 2019, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical SBBP trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Calm After Storm Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.85%
Calm After Storm Range Contraction -4.85%
Inside Day Range Contraction -4.85%
Wide Bands Range Expansion -4.85%

Older signals for SBBP ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Strongbridge Biopharma plc, a biopharmaceutical company, through its subsidiary, Cortendo AB (publ), develops, acquires, and commercializes product candidates that target rare diseases. The company's lead product candidate, COR-003 (levoketoconazole), is a cortisol inhibitor that is in the Phase 3 trial for the treatment of endogenous Cushing's syndrome. It also has two product candidates, COR-004 and COR-005 in Phase 2 clinical development to treat acromegaly. In addition, it is developing BP-2001, a pre-clinical product candidate for the treatment of diabetes. The company was formerly known as Cortendo plc and changed its name to Strongbridge Biopharma plc in September 2015. Strongbridge Biopharma plc was founded in 1996 and is based in Trevose, Pennsylvania.
Chemistry Biopharmaceutical Organ Systems Chemical Compounds Diabetes Rare Diseases Chloroarenes Treatment Of Diabetes Acromegaly Cushing's Syndrome Adrenal Gland Disorders Cortisol Endogenous Cushing's Syndrome Piperazines
Is SBBP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.69
52 Week Low 1.45
Average Volume 352,958
200-Day Moving Average 3.3683
50-Day Moving Average 2.253
20-Day Moving Average 1.954
10-Day Moving Average 1.863
Average True Range 0.191
ADX 28.99
+DI 14.6125
-DI 33.2273
Chandelier Exit (Long, 3 ATRs ) 1.907
Chandelier Exit (Short, 3 ATRs ) 2.023
Upper Bollinger Band 2.4293
Lower Bollinger Band 1.4787
Percent B (%b) 0.1
BandWidth 48.648925
MACD Line -0.1545
MACD Signal Line -0.1178
MACD Histogram -0.0367
Fundamentals Value
Market Cap 55.48 Million
Num Shares 35.3 Million
EPS -2.93
Price-to-Earnings (P/E) Ratio -0.54
Price-to-Sales 139.82
Price-to-Book 21.76
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.80
Resistance 3 (R3) 1.82 1.76 1.76
Resistance 2 (R2) 1.76 1.71 1.75 1.74
Resistance 1 (R1) 1.67 1.67 1.64 1.65 1.73
Pivot Point 1.61 1.61 1.60 1.60 1.61
Support 1 (S1) 1.52 1.56 1.49 1.50 1.41
Support 2 (S2) 1.46 1.52 1.45 1.40
Support 3 (S3) 1.37 1.46 1.38
Support 4 (S4) 1.35